CA1224416A - Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin - Google Patents

Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Info

Publication number
CA1224416A
CA1224416A CA000442829A CA442829A CA1224416A CA 1224416 A CA1224416 A CA 1224416A CA 000442829 A CA000442829 A CA 000442829A CA 442829 A CA442829 A CA 442829A CA 1224416 A CA1224416 A CA 1224416A
Authority
CA
Canada
Prior art keywords
composition according
component
molecular weight
pharmaceutically acceptable
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000442829A
Other languages
English (en)
French (fr)
Inventor
Hans Buhlmann
Dieter Welzel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1224416A publication Critical patent/CA1224416A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000442829A 1982-12-10 1983-12-08 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin Expired CA1224416A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10
DEP3245695.6 1982-12-10

Publications (1)

Publication Number Publication Date
CA1224416A true CA1224416A (en) 1987-07-21

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000442829A Expired CA1224416A (en) 1982-12-10 1983-12-08 Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin

Country Status (25)

Country Link
JP (1) JPH0672101B2 (OSRAM)
AT (1) AT382514B (OSRAM)
AU (1) AU570658B2 (OSRAM)
BE (1) BE898356A (OSRAM)
CA (1) CA1224416A (OSRAM)
CH (1) CH656533A5 (OSRAM)
CY (1) CY1509A (OSRAM)
DD (1) DD215469B3 (OSRAM)
DK (1) DK162475C (OSRAM)
FR (1) FR2537435B1 (OSRAM)
GB (1) GB2131691B (OSRAM)
GR (1) GR79745B (OSRAM)
HK (1) HK23290A (OSRAM)
HU (1) HU190513B (OSRAM)
IE (1) IE56366B1 (OSRAM)
IL (1) IL70406A (OSRAM)
IT (1) IT1172368B (OSRAM)
LU (1) LU85127A1 (OSRAM)
NL (1) NL8304221A (OSRAM)
NZ (1) NZ206523A (OSRAM)
PH (1) PH23451A (OSRAM)
PT (1) PT77803B (OSRAM)
SE (1) SE468973B (OSRAM)
SG (1) SG53989G (OSRAM)
ZA (1) ZA839200B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
GR79745B (OSRAM) 1984-10-31
IT8349456A0 (it) 1983-12-07
SG53989G (en) 1989-12-29
JPS59116222A (ja) 1984-07-05
DK162475C (da) 1992-05-11
GB2131691B (en) 1986-12-03
SE468973B (sv) 1993-04-26
NL8304221A (nl) 1984-07-02
DK162475B (da) 1991-11-04
NZ206523A (en) 1987-04-30
PH23451A (en) 1989-08-07
IT8349456A1 (it) 1985-06-07
BE898356A (fr) 1984-06-04
FR2537435A1 (fr) 1984-06-15
DK565783D0 (da) 1983-12-08
CH656533A5 (de) 1986-07-15
FR2537435B1 (fr) 1987-03-20
HK23290A (en) 1990-04-06
PT77803A (en) 1984-01-01
CY1509A (en) 1990-08-03
IT1172368B (it) 1987-06-18
DK565783A (da) 1984-06-11
IL70406A0 (en) 1984-03-30
DD215469B3 (de) 1988-03-09
DD215469A5 (de) 1984-11-14
SE8306792D0 (sv) 1983-12-08
HUT34124A (en) 1985-02-28
IE832896L (en) 1984-06-10
IE56366B1 (en) 1991-07-03
GB8332653D0 (en) 1984-01-11
JPH0672101B2 (ja) 1994-09-14
ZA839200B (en) 1985-07-31
IL70406A (en) 1988-08-31
LU85127A1 (fr) 1984-10-22
PT77803B (en) 1986-04-17
SE8306792L (sv) 1984-06-11
AU570658B2 (en) 1988-03-24
HU190513B (en) 1986-09-29
GB2131691A (en) 1984-06-27
AT382514B (de) 1987-03-10
ATA428483A (de) 1986-08-15
AU2222183A (en) 1984-06-14

Similar Documents

Publication Publication Date Title
US6224857B1 (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
EP0213514B1 (en) Aqueous liquid preparation
DE69019774T2 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
EP0444492B1 (en) Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment
US6103741A (en) Analgesic agent and its use
EP3760207A1 (en) Ophthalmic composition comprising diquafosol and cationic polymer
DE60029340T2 (de) Pharmazeutische zusammenstellungen enthaltend einen p2t rezeptor antagonist und melagatran
US4777161A (en) Medicaments favoring the properties of blood flow and their use in therapeutics
EP0233615B1 (en) Aqueous preparation and method of preparation thereof
CA1224416A (en) Pharmaceutical compositions comprising an hydrogenated ergot alkaloid and heparin
DE69518706T2 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
PT95511B (pt) Processo de producao de glicosaminoglicuronano sulfato e de composicoes farmaceuticas
Mayer et al. Efficacy of a novel hydrogel formulation in human volunteers
EP0728479A1 (en) Deacetyl moxisylyte in the treatment of acute urinary retention
RU2218156C2 (ru) Способ изготовления состава местных бета-блокаторов улучшенного действия
US6110926A (en) Eyedrop composition
CN114364401A (zh) 防止含有对二羟硼基苯丙氨酸的注射液剂的析出的方法
KR101841902B1 (ko) 플루오로메톨론 아세테이트를 유효성분으로 포함하는 투명 점안제
JPH01299227A (ja) ロドカインを使用する眼科用麻酔薬剤
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
US7645765B2 (en) Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
KR19990023971A (ko) 크로만 유도체를 함유하는 안과용 용제
HK40063208A (en) Method for preventing precipitation of injectable solution containing p-boronophenylalanine
EP0396169A2 (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
JPS6340166B2 (OSRAM)

Legal Events

Date Code Title Description
MKEX Expiry